Hjem › Akut lymfoblastisk leukæmi › Indiana › Indianapolis
Akut lymfoblastisk leukæmi kliniske forsøg i Indianapolis, IN
5 studier for Akut lymfoblastisk leukæmi søger deltagere på steder i og omkring Indianapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RekruttererFase 1
- Riley Children's Hosptial, Indianapolis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservationsstudie
- Indiana University/Riley Hospital for Children, Indianapolis
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RekruttererFase 3
- Ascentage Investigative Site #1158, Indianapolis
- Ascentage Investigative Site #1069, Indianapolis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Riley Hospital for Children, Indianapolis
Akut lymfoblastisk leukæmi forsøg i andre byer
- Houston, TX28 studier
- New York City, NY24 studier
- Baldwin Park, CA21 studier
- Seattle, WA21 studier
- Chicago, IL19 studier
- Atlanta, GA19 studier
- Philadelphia, PA16 studier
- Memphis, TN16 studier
- Washington, DC16 studier
- Boston, MA15 studier
- Los Angeles, CA14 studier
- Durham, NC13 studier
Andre studier i Indianapolis
- Ikke-småcellet lungecancer32 studier
- Kræft (alle typer)24 studier
- Hjertesvigt23 studier
- Brystkræft20 studier
- Overvægt20 studier
- Metastatisk cancer19 studier
- Colorektal kræft18 studier
- Ægstockræft17 studier
- Lungecancer16 studier
- Kardiovaskulær sygdom16 studier
- Type 1-diabetes14 studier
- Livmoderslimhindekræft14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.